Berlin Cures GmbH
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID (NCT05911009) | Berlin Cures GmbH | 2023-06-16 |
| The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor (NCT04192214) | Berlin Cures GmbH | 2019-03-29 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of BC 007 in Healthy Subjects (NCT02955420) | Berlin Cures GmbH | 2016-08-01 |
Track Berlin Cures GmbH automatically
Every clearance here is in the API, with alerts when new ones post.